Literature DB >> 22022856

Factors related to past HIV testing among South African non-injection drug users.

Lauren R Ropelewski1, Alicia Hulbert, William W Latimer.   

Abstract

South Africa has some of the highest estimates of human immunodeficiency virus (HIV) in the world, with a prevalence of 21.5%. Despite this, based on population-level data, 39% of sexually active South Africans have never been tested for HIV. Non-injection drug users (NIDUs) are a high-risk and increasingly prevalent group in South Africa. However, few studies have examined HIV test utilization among high-risk groups such as drug users in South Africa. The study was conducted in Pretoria, South Africa between 2002 and 2006. Of the 382 individuals surveyed, 31% had been tested for HIV in the past. Results indicate that females and older individuals were significantly more likely to have been tested for HIV at some point in the past, while individuals who did not know someone with HIV/AIDS as well as individuals who are unsure of their risk of HIV infection were significantly less likely to have ever accessed testing. Identification of these subgroups has implications for the development of targeted interventions to promote greater HIV testing among at-risk groups in South Africa.

Entities:  

Mesh:

Year:  2011        PMID: 22022856      PMCID: PMC3205418          DOI: 10.1080/09540121.2011.582479

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  27 in total

1.  Trends of HIV-1 risk reduction among initiates into intravenous drug use 1982-1987.

Authors:  D Vlahov; J C Anthony; D Celentano; L Solomon; N Chowdhury
Journal:  Am J Drug Alcohol Abuse       Date:  1991       Impact factor: 3.829

Review 2.  Changing AIDS-risk behavior.

Authors:  J D Fisher; W A Fisher
Journal:  Psychol Bull       Date:  1992-05       Impact factor: 17.737

3.  Health services utilization among South African women living with HIV and reporting sexual and substance-use risk behaviors.

Authors:  Winnie K Luseno; Wendee M Wechsberg; Tracy L Kline; Rachel Middlesteadt Ellerson
Journal:  AIDS Patient Care STDS       Date:  2010-04       Impact factor: 5.078

4.  HIV-testing behavior among young migrant men who have sex with men (MSM) in Beijing, China.

Authors:  Yan Song; Xiaoming Li; Liying Zhang; Xiaoyi Fang; Xiuyun Lin; Yinjie Liu; Bonita Stanton
Journal:  AIDS Care       Date:  2011-02

5.  Gender differences in behavioural and psychosocial predictors of HIV testing and return for test results in a high-risk population.

Authors:  J A Stein; A Nyamathi
Journal:  AIDS Care       Date:  2000-06

6.  Relative risk of HIV infection among young men and women in a South African township.

Authors:  C MacPhail; B G Williams; C Campbell
Journal:  Int J STD AIDS       Date:  2002-05       Impact factor: 1.359

7.  HIV testing attitudes, AIDS stigma, and voluntary HIV counselling and testing in a black township in Cape Town, South Africa.

Authors:  S C Kalichman; L C Simbayi
Journal:  Sex Transm Infect       Date:  2003-12       Impact factor: 3.519

8.  Attitudes towards HIV-antibody testing and people with AIDS among university students in India, South Africa and United States.

Authors:  Karl Peltzer; Esther Nzewi; Krishna Mohan
Journal:  Indian J Med Sci       Date:  2004-03

9.  Factors associated with HIV testing among public sector clinic attendees in Johannesburg, South Africa.

Authors:  Audrey Pettifor; Catherine MacPhail; Sujit Suchindran; Sinead Delany-Moretlwe
Journal:  AIDS Behav       Date:  2008-10-18

10.  South African national household survey of HIV/AIDS prevalence, behavioural risks and mass media impact--detailed methodology and response rate results.

Authors:  Olive Shisana; David Stoker; Leickness Chisamu Simbayi; Mark Orkin; Francois Bezuidenhout; Sean Edwin Jooste; Mark Colvin; Johan van Zyl
Journal:  S Afr Med J       Date:  2004-04
View more
  1 in total

1.  Changes in self-reported HIV testing during South Africa's 2010/2011 national testing campaign: gains and shortfalls.

Authors:  Brendan Maughan-Brown; Neil Lloyd; Jacob Bor; Atheendar S Venkataramani
Journal:  J Int AIDS Soc       Date:  2016-04-11       Impact factor: 6.707

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.